Journal article
Chlamydia trachomatis and Mycoplasma genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception clinic, 2009-2019
HS Shilling, SM Garland, AM Costa, A Marceglia, K Fethers, J Danielewski, G Murray, C Bradshaw, L Vodstrcil, JS Hocking, J Kaldor, R Guy, DA MacHalek
Sexually Transmitted Infections | BMJ PUBLISHING GROUP | Published : 2022
Abstract
Background Risk of pelvic inflammatory disease associated with Chlamydia trachomatis and Mycoplasma genitalium is increased after termination of pregnancy (TOP) and may be increased after insertion of intrauterine devices (IUDs). Screening prior to these procedures is recommended only for C. trachomatis. We examined C. trachomatis and M. genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception service over 10 years. Methods Retrospective analysis of clinical data collected from 17 573 women aged 15-45 years in 2009-2019 and for 266 M. genitalium positive women tested for macrolide resistance-associated mutations in 2016-2019. Results C...
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
The work was supported by National Health and Medical Research Council program (Grant number 568971).